Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122842965 | 12284296 | 5 | F | 20160216 | 20160705 | 20160420 | 20160711 | EXP | JP-009507513-1604JPN011784 | MERCK | 74.00 | YR | F | Y | 42.00000 | KG | 20160711 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122842965 | 12284296 | 1 | PS | TEMODAL | TEMOZOLOMIDE | 1 | Oral | DAILY DOSAGE UNKNOWN | 21029 | CAPSULE | |||||||||
| 122842965 | 12284296 | 2 | SS | BAKTAR | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | EVERY OTHER DAY, IN THE MORNING AND EVENING | 30 | DF | 0 | 1 | DF | TABLET | BID | ||||
| 122842965 | 12284296 | 3 | SS | E KEPPRA | LEVETIRACETAM | 1 | Oral | 500 MG, TWICE A DAY | 49000 | MG | 0 | 500 | MG | TABLET | BID | ||||
| 122842965 | 12284296 | 4 | C | ADALAT CC | NIFEDIPINE | 1 | Oral | 40 MG, QD, , DIVIDED DOSE FREQUENCY UNKNOWN. | U | 0 | 40 | MG | TABLET | QD | |||||
| 122842965 | 12284296 | 5 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Oral | 330 MG, TID | U | 0 | 330 | MG | TABLET | TID | |||||
| 122842965 | 12284296 | 6 | C | OLMETEC | OLMESARTAN MEDOXOMIL | 1 | Oral | 10 MG, DIVIDED DOSE, FREQUENCY UNKNOWN | U | 0 | 10 | MG | TABLET | QD | |||||
| 122842965 | 12284296 | 7 | C | WARKMIN | ALFACALCIDOL | 1 | Oral | 0.5 MICROGRAM, DIVIDED DOSE, FREQUENCY UNKNOWN | U | 0 | .5 | UG | CAPSULE | QD | |||||
| 122842965 | 12284296 | 8 | C | ETIZOLAM | ETIZOLAM | 1 | Oral | 0.5 MG, QD | U | 0 | .5 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122842965 | 12284296 | 1 | Glioblastoma |
| 122842965 | 12284296 | 2 | Prophylaxis |
| 122842965 | 12284296 | 3 | Prophylaxis |
| 122842965 | 12284296 | 4 | Hypertension |
| 122842965 | 12284296 | 5 | Constipation |
| 122842965 | 12284296 | 6 | Hypertension |
| 122842965 | 12284296 | 7 | Anxiety |
| 122842965 | 12284296 | 8 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122842965 | 12284296 | OT |
| 122842965 | 12284296 | DS |
| 122842965 | 12284296 | HO |
| 122842965 | 12284296 | DE |
| 122842965 | 12284296 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122842965 | 12284296 | Blood pressure decreased | |
| 122842965 | 12284296 | Cerebral infarction | |
| 122842965 | 12284296 | Device related infection | |
| 122842965 | 12284296 | Diarrhoea | |
| 122842965 | 12284296 | Disseminated intravascular coagulation | |
| 122842965 | 12284296 | Generalised oedema | |
| 122842965 | 12284296 | Hypoalbuminaemia | |
| 122842965 | 12284296 | Hypophagia | |
| 122842965 | 12284296 | Lymphocyte count decreased | |
| 122842965 | 12284296 | Multiple organ dysfunction syndrome | |
| 122842965 | 12284296 | Rash | |
| 122842965 | 12284296 | Renal disorder | |
| 122842965 | 12284296 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122842965 | 12284296 | 1 | 20160113 | 20160224 | 0 | |
| 122842965 | 12284296 | 2 | 20160216 | 20160301 | 0 | |
| 122842965 | 12284296 | 3 | 20160113 | 20160301 | 0 | |
| 122842965 | 12284296 | 4 | 20160301 | 0 | ||
| 122842965 | 12284296 | 5 | 20160301 | 0 | ||
| 122842965 | 12284296 | 6 | 20160301 | 0 | ||
| 122842965 | 12284296 | 7 | 20160301 | 0 | ||
| 122842965 | 12284296 | 8 | 20160301 | 0 |